Therapeutical doses of temozolomide do not impair the function of dendritic cells and CD8+ T cells
Open Access
- 23 November 2011
- journal article
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 40 (3) , 764-772
Abstract
The median survival of patients with glioblastoma multiforme (GBM) remains poor. Innovative immunotherapies with dendritic cell (DC) vaccination might be combined with standard temozolomide (TMZ) treatment. Here, we evaluated the influence of TMZ on the phenotype and function of DCs and CD8+ T cells. DCs were generated from the peripheral blood of healthy volunteers (HVs) and GBM patients. DCs were analyzed by light microscopy and flow cytometry. Phagocytic activity was tested by FITC-dextran engulfment. Mixed lymphocyte peptide cultures were followed by enzyme-linked immunospot (ELISPOT) and flow cytometry assays. TMZ was added to DC and T cell cultures at concentrations up to 500 µM. Mature DCs were generated from HVs and GBM patients. Cells displayed a typical DC morphology and a mature DC phenotype. Expression of CD209 was even higher in DCs generated from patients under therapy than from HVs (75.2 vs. 51.1%). In contrast, CD40 (1.1 vs. 13.5%) and BDCA4 (26.5 vs. 52.9%) were lower expressed in GBM patients at time of diagnosis. Immature DCs showed high phagocytic activity. Addition of TMZ at concentrations up to 50 µM did neither impair the phenotype nor the function of DCs. In ELISPOT and flow cytometry assays, no impairment of CD8+ T cell responses to viral antigens could be observed. Taken together, TMZ does not impair the function of either DCs or the CD8+ T cells.Keywords
This publication has 29 references indexed in Scilit:
- Continuous low-dose temozolomide and celecoxib in recurrent glioblastomaJournal of Neuro-Oncology, 2010
- Effects of Concomitant Temozolomide and Radiation Therapies on WT1-specific T-cells in Malignant GliomaJapanese Journal of Clinical Oncology, 2010
- Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot studyJournal of Neuro-Oncology, 2010
- Identification of a naturally processed T cell epitope derived from the glioma-associated protein SOX11Cancer Letters, 2007
- Ligand recognition by antigen-presenting cell C-type lectin receptorsCurrent Opinion in Immunology, 2005
- Dendritic cells generated from acute myeloid leukemia (AML) blasts maintain the expression of immunogenic leukemia associated antigensCancer Immunology, Immunotherapy, 2004
- Surgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility studyBritish Journal of Cancer, 2004
- Tumor mRNA?loaded dendritic cells elicit tumor-specific CD8+ cytotoxic T cells in patients with malignant gliomaCancer Immunology, Immunotherapy, 2003
- Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trialBritish Journal of Cancer, 2003
- Exceptional sensitivity of testicular germ cell tumour cell lines to the new anti-cancer agent, temozolomideBritish Journal of Cancer, 1995